Profitability Ratios
| Ratio |
Value |
| GP Margin |
88.5% |
| EBIT Margin |
48.2% |
| EBITDA Margin |
53.0% |
| Operating Margin |
48.2% |
| Pretax Margin |
48.1% |
| Cont. Ops Margin |
52.3% |
| Net Margin |
52.3% |
| Bottom Line Margin |
52.3% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
2.11 |
| Quick Ratio |
1.94 |
| Solvency Ratio |
0.423 |
| Cash Ratio |
0.84 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
-0.01 |
| Forward PEG |
-0.01 |
| Price/Book |
2.07 |
| Price/Sales |
2.69 |
| Price/FCF |
4.85 |
| Price/Op Cash Flow |
4.79 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.1803 |
| Debt/Equity |
0.3674 |
| Debt/Capital |
0.2687 |
| Long-Term Debt/Capital |
0.2630 |
| Financial Leverage |
2.04 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
2.28 |
| Operating Cash Flow Ratio |
1.004 |
| Operating Cash Flow/Sales |
56.2% |
| Free Cash Flow/Operating Cash Flow |
98.7% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
64.04 |
| Interest Coverage |
53.9687 |
| Short-Term Operating Cash Flow Coverage |
0.00 |
| Operating Cash Flow Coverage |
1.18 |
| Capital Expenditure Coverage |
77.45 |
| Dividend + Capital Expenditure Coverage |
77.45 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
0.0000% |
| Dividend Yield |
0.0000% |
| Dividend Yield % |
0.0000% |
| Dividend Per Share |
0.0000 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
4.33 |
| EPS |
2.264 |
| Debt/Share |
2.1059 |
| Cash/Share |
2.08 |
| Book Value/Share |
5.63 |
| Tangible BV/Share |
-0.05 |
| Equity/Share |
5.63 |
| Operating Cash Flow/Share |
2.430 |
| Capital Expenditure/Share |
0.031 |
| FCF/Share |
2.399 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
1.087 |
| Earnings Before Tax/EBIT |
0.999 |
| Price/Fair Value |
2.07 |
| Debt/Market Cap |
0.1726 |
| Effective Tax Rate |
-8.7% |
| Enterprise Value Multiple |
5.09 |
CRMD - CorMedix Inc.